Is Bionano Genomics Inc (BNGO) overvalued? · rev $14.9M
Bionano Genomics Inc (BNGO) is a medical instruments & supplies company listed on US.
This page asks whether Bionano Genomics Inc (BNGO) looks expensive on cached numbers — not a short thesis.
Latest reported BNGO revenue for 2026-06-30 was $14.9M. Net income was -$15.7M. BNGO currently screens at market cap $13.4M.
BNGO currently screens at market cap $13.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next BNGO 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the BNGO stock page for the full model, not this heading.
Not investment advice.